HSCI has two faculty co-directors, appointed by the Provost, who have overall responsibility for running the Institute. The co-directors are Douglas Melton, who is the Thomas Dudley Cabot Professor of the Natural Sciences in the Faculty of Arts and Sciences and a Howard Hughes Medical Investigator; and David Scadden, Professor of Medicine at Harvard Medical School and Director of the Center for Regenerative Medicine at Massachusetts General Hospital.
The directors are advised by a faculty executive committee representing the Harvard schools and teaching hospitals. This committee is responsible for providing overall guidance to the Institute and for convening the various advisory subcommittees that will help to shape its strategy. These subcommittees include a grant review committee, with representatives from the main institutions involved in HSCI, as well as working groups in each of the areas of interest to HSCI.
|Douglas A. Melton, PhD||Harvard University Department of Stem Cell and Regenerative Biology
Howard Hughes Medical Institute
|David T. Scadden, MD||Harvard University Department of Stem Cell and Regenerative Biology
Massachusetts General Hospital
|Brock Reeve, MPhil, MBA||Harvard Stem Cell Institutefirstname.lastname@example.org|
Scientific Advisory Board
|Fred Appelbaum, MD, PhD||Fred Hutchinson Cancer Research Center|
|Paul Berg, PhD||Stanford University School of Medicine, Nobel Laureate|
|Mark C. Fishman, MD||Novartis Institutes for BioMedical Research|
|Sir John Gurdon, PhD||The Wellcome Trust, Cambridge University, Gurdon Institute|
|Zach W. Hall, PhD||Former President, California Institute for Regenerative Medicine|
|Fiona Watt, DPhil||Cambridge University, UK|